Finding 564130 (2021-001)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2021
Accepted
2025-06-06
Audit: 358269
Organization: Biotex,inc (TX)
Auditor: Abip PC

AI Summary

  • Issue: The Company did not submit the Single Audit Report on time for the year ended December 31, 2021.
  • Impact: This delay led to non-compliance with federal requirements, potentially affecting future funding opportunities.
  • Follow-up: Review and improve grant management procedures to ensure timely reporting for federal funding; implementation is expected by August 2024.

Finding Text

Condition: The Company did not timely submit the Single Audit Report to the National Heart, Lung, and Blood Institute for the year ended December 31, 2021. Criteria or specific requirement: According to the Uniform Guidance, recipients must submit a Single Audit Report or other applicable report that states whether the audit or examination was completed and provide information about the auditee, its federal programs, and the results of the audit or examination submitted within the earlier of 30 days after receipt of the auditor’s report, or nine months after the end of the audit period. Effect: The delay in filing resulted in non-compliance with regulatory requirements, this could impact affect future funding from various agencies. Cause: The Company received funds in response to the Coronavirus disease pandemic. There were no proper policies and procedures in place for federal award reporting, as the Company does not regularly receive federal funding.Recommendation: We recommend that a review of grant management documentation procedures to ensure controls are in place to support proper filing and reporting procedures for federal funding. Management’s view: Management agrees with the condition described. Proposed corrective action: This is the first time the company has been required to submit an audit and was new to this reporting requirement. Once we became aware of the requirement, we quickly remedied the situation; it has been documented as an extra step in our Grant management accounting process and will be complied with going forward. Anticipated correction date: This has been implemented effective August 2024. Responsible official: Ashok Gowda

Corrective Action Plan

Proposed corrective action: This is the first time the company has been required to submit an audit and was new to this reporting requirement. Once we became aware of the requirement, we quickly remedied the situation; it has been documented as an extra step in our Grant management accounting process and will be complied with going forward. Anticipated correction date: This has been implemented effective August 2024.

Categories

Reporting

Other Findings in this Audit

  • 564131 2021-001
    Significant Deficiency
  • 1140572 2021-001
    Significant Deficiency
  • 1140573 2021-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.865 Child Health and Human Development Extramural Research $380,696
93.837 Cardiovascular Diseases Research $187,171